Product Images Ropivacaine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Ropivacaine Hydrochloride NDC 0409-9303 by Hospira, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structural formula ropivacaine hcl - ropivacaine 01

structural formula ropivacaine hcl - ropivacaine 01

Hospira logo - ropivacaine 02

Hospira logo - ropivacaine 02

PRINCIPAL DISPLAY PANEL - 20 mg/10 mL Vial Label - ropivacaine 03

PRINCIPAL DISPLAY PANEL - 20 mg/10 mL Vial Label - ropivacaine 03

This is a description of a prescription medication containing Ropivacaine HC1, which is provided in single-dose vials. The medication is intended for use in infiltration, nerve block, and epidural administration only and should not be used intravenously. It is important not to use the medication if the solution is discolored or contains a precipitate. The normal dosage should be determined by reading the package insert. The medication is stored at a temperature range of 20-25 degrees Celsius (68-77 degrees Fahrenheit).*

PRINCIPAL DISPLAY PANEL - 20 mg/10 mL Vial Carton - ropivacaine 04

PRINCIPAL DISPLAY PANEL - 20 mg/10 mL Vial Carton - ropivacaine 04

This is a label for a medication called Ropivacaine Hydrochloride Injection, which comes in a box of 10 single-dose vials, each containing 10 mL of solution for infiltration, nerve block, and epidural administration. The solution contains 2mg of Ropivacaine HCI and 86mg of sodium chloride per mL, and has a pH between 4.0-6.0, with no preservatives. The package insert should be followed for the correct dosage. The solution should not be used if it is discolored or has precipitates, and the unused portion should be discarded. It can be auto-claved as per instructions in the package insert. The label also includes the NDC number and manufacturing details.*

PRINCIPAL DISPLAY PANEL - 40 mg/20 mL Vial Label - ropivacaine 05

PRINCIPAL DISPLAY PANEL - 40 mg/20 mL Vial Label - ropivacaine 05

This is a description of a medication called Ropivacaine HCI available in a 20 mL Single-Dose Vial. The solution contains 2 mg of Ropivacaine HCI per mL and Sodium Chloride. It also contains Sodium Hydroxide and/or Hydrochloric Acid for adjustment of pH. The substance has no preservatives and should not be used if the solution is discolored or contains a precipitate. The dosage varies and can be seen in the accompanying package insert. The medication is not for Intravenous Administration and is only used for Infiltration, Nerve Block, and Epidural Administration. The unused portion of the medication should be discarded, and the medication should be stored at a controlled temperature of 20° to 25°C (68° to 77°F). The medication is distributed by Hospira and is available through prescription only.*

PRINCIPAL DISPLAY PANEL - 40 mg/20 mL Vial Carton - ropivacaine 06

PRINCIPAL DISPLAY PANEL - 40 mg/20 mL Vial Carton - ropivacaine 06

This is a description of a pharmaceutical product. The product is a 10-pack of 20 mL single-dose vials with the brand name Ronly and NDC code 0409930020, containing 0.20%/0.40 mg of Ropivacaine Hydrochloride Injection, USP. The solution is intended for Infiltration, Nerve Block, and Epidural Administration Only, and should not be administered intravenously. Each vial contains Ropivacaine Kl 2 mg and Sodium Chloride 85 mg. The Sodium hydroids and/or hydrochloric acid is added to adjust the pH of the solution to 4.0-6.0, and the solution contains no preservatives. It has practical instructions on usage, storage conditions, and proper disposal. The product is manufactured in South Africa by Hospira, Inc., Lake. The description also includes a GTIN number of 10304099300209, lot number HARHHAR, and an expiration date that is not available in the text.*

PRINCIPAL DISPLAY PANEL - 150 mg/30 mL Vial Label - ropivacaine 07

PRINCIPAL DISPLAY PANEL - 150 mg/30 mL Vial Label - ropivacaine 07

This is a prescription medicine in a 30ml vial containing Ropivacaine Hydrochloride for infiltration, nerve block, and epidural administration. It should not be used intravenously and should be discarded if discolored or contains a precipitate. It should be stored at controlled room temperature between 20°to 25°C. The usual dosage can be found in the package insert. This medicine is distributed by Hospira, Inc., located in Lake Forest, IL, USA.*

PRINCIPAL DISPLAY PANEL - 150 mg/30 mL Vial Carton - ropivacaine 08

PRINCIPAL DISPLAY PANEL - 150 mg/30 mL Vial Carton - ropivacaine 08

This text provides information about a prescription drug called Ropivacaine Hydrochloride Injection, USP. The drug comes in a package of 10 single-dose vials, containing 150mg/30mL of the solution, at a concentration of 5 mg/mL. The package is for Rxonly use and has the NDC (National Drug Code) number 0409-9301-20. The drug's manufacturing location is South Africa. The text also includes instructions on dosage and storage, cautionary information and warnings, and general information about the drug's composition.*

PRINCIPAL DISPLAY PANEL - 150 mg/20 mL Vial Label - ropivacaine 09

PRINCIPAL DISPLAY PANEL - 150 mg/20 mL Vial Label - ropivacaine 09

This is a description of a prescription drug called Ropivac, which is available in a 20 ml single-dose vial for nerve block and epidural administration. The drug contains Ropivacaine HCI, sodium chloride, and can be adjusted with sodium hydroxide and/or hydrochloric acid to adjust pH. It does not contain preservatives and the usual dosage should be followed as per the package insert. It is recommended I not to use if the solution is discolored or provides a precipitate. This drug is not for intravenous administration and should be stored at 20 to 25°C (68 to 77°F). The manufacturer is Hospira, Inc. and the product contains 150 mg/2ml.*

PRINCIPAL DISPLAY PANEL - 150 mg/20 mL Vial Carton - ropivacaine 10

PRINCIPAL DISPLAY PANEL - 150 mg/20 mL Vial Carton - ropivacaine 10

This is a description of a medication called Ropivacaine Hydrochloride Injection. The medication comes in a package of 10 single-dose vials, each containing 20mL of the solution. The drug is intended for nerve block and epidural administration only and should not be administered intravenously. Each vial contains 150mg/20mL of the drug at a concentration of 7.5mg/mL. The drug is made in South Africa and is distributed by a company called Hosir, based in Illinois, USA. The usual dosage is not provided. The description also includes instructions for storage and use of the medication.*

PRINCIPAL DISPLAY PANEL - 100 mg/10 mL Vial Label - ropivacaine 11

PRINCIPAL DISPLAY PANEL - 100 mg/10 mL Vial Label - ropivacaine 11

This is a medication called 1T Rxonly which is a single-dose vial of Ropivacaine HCI. Each mL of this solution contains 10 mg of Ropivacaine HCI, 7.1 mg of Sodium chloride and Hydrochloride to adjust pH to 4.6. It does not contain any preservatives. The usual dosage and instructions can be found in the package insert. This medication is not suitable for use if the solution is discolored or has any precipitate. It is meant to be used only for epidural administration and should not be administered intravenously. The medication is distributed by Hospira, Inc., and should be stored at room temperature.*

PRINCIPAL DISPLAY PANEL - 100 mg/10 mL Vial Carton - ropivacaine 12

PRINCIPAL DISPLAY PANEL - 100 mg/10 mL Vial Carton - ropivacaine 12

This is a description of a medication package containing 10 single-dose vials of 10 mL each. The medication is Ropivacaine Hydrochloride Injection, USP, with a concentration of 100 mg/10 mL (10 mg/mL). It is for epidural administration only and not for intravenous use. Each mL contains Ropivacaine at 10mg and Sodium Chloride at 7.1mg. The solution can be autoclaved and should be stored at 20°C-25°C (68°F-77°F). The package should be discarded if the solution is discolored or contains a precipitate. The medication is made in South Africa and distributed by Hospira, Inc. in Illinois, USA.*

PRINCIPAL DISPLAY PANEL - 200 mg/20 mL Vial Label - ropivacaine 13

PRINCIPAL DISPLAY PANEL - 200 mg/20 mL Vial Label - ropivacaine 13

Ropivacaine Hydrochloride Injection, USP is a medication to be used for epidural administration only, not for intravenous administration. It is provided in a 20 mL single-dose vial, and each mL contains Ropivacaine HCI 10 mg, Sodium chloride 7.1 mg, and Sodium hydroxide and/or hydrochloric acid to adjust pH t0 4.0 6.0. The medication contains no preservatives, and its usual dosage can be seen in the package insert. It should not be used if the solution is discolored or contains a precipitate. Any unused portion should be discarded, and the medication should be stored at 20°C to 5°C (68°F to 77°F) [See USP Controlled Room Temperature]. It is distributed by Hospira, Inc. in Lake Forest [L 60045 USA].*

PRINCIPAL DISPLAY PANEL - 200 mg/20 mL Vial Carton - ropivacaine 14

PRINCIPAL DISPLAY PANEL - 200 mg/20 mL Vial Carton - ropivacaine 14

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.